Docetaxel, Carboplatin and Concomitant Radiotherapy for Unresectable Squamous Cell Carcinoma of the Head and Neck-Reference-Cited by-同舟云学术

Docetaxel, Carboplatin and Concomitant Radiotherapy for Unresectable Squamous Cell Carcinoma of the Head and Neck

Published:2004-04 Issue:2 Volume:27 Page:155-163
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Airoldi Mario,Cattel Luigi,Cortesina Giorgio,Giordano Carlo,Pedani Fulvia,Recalenda Valeria,Danova Marco,Gabriele Anna Maria,Tagini Valeria,Porta Camillo,Bumma Cesare

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference40 articles.

1. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

2. Concomitant Radiotherapy and Daily Low-Dose Carboplatin in Locally Advanced, Unresectable Head and Neck Cancer Definitive results of a phase I-II study

3. Carboplatin (CBDCA) + radiotherapy (RT) vs RT in inoperable stage III–IV head and neck (HN) carcinoma

4. Docetaxel: an active drug for squamous cell carcinoma of the head and neck.

5. Management of head and neck cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival After Definitive Chemoradiotherapy With Concurrent Cisplatin or Carboplatin for Head and Neck Cancer;Journal of the National Comprehensive Cancer Network;2019-09

2. Oral complications of radiotherapy: approaches to prevention and treatment;Kazan medical journal;2015-06-15

3. Taxanes in cancer of the head and neck;Anti-Cancer Drugs;2014-06

4. Concurrent chemoradiation with weekly Cisplatin, Docetaxel and Gefitinib: A study to assess feasibility, toxicity and immediate response;Journal of Cancer Research and Therapeutics;2013

5. Number Needed to Treat Analysis for Planned Neck Dissection after Chemoradiotherapy for Advanced Neck Disease;J OTOLARYNGOL-HEAD N;2010